262 related articles for article (PubMed ID: 12240505)
1. Imiquimod (Aldara): modifying the immune response.
Rudy SJ
Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod as an immune response modulator in infectious conditions.
Skinner RB
Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
[TBL] [Abstract][Full Text] [Related]
3. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Hengge UR; Cusini M
Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory therapy in the management of viral infections in patients with HIV infection.
Conant MA
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S27-30. PubMed ID: 10861104
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
8. Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Berman B; Hengge U; Barton S
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):12-7. PubMed ID: 14606277
[No Abstract] [Full Text] [Related]
9. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod in clinical practice.
Edwards L
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
12. [Imiquimod and immune response modifiers in gynaecology].
Baulon E; Vautravers A; Rodriguez B; Nisand I; Baldauf JJ
Gynecol Obstet Fertil; 2007 Feb; 35(2):149-57. PubMed ID: 17300975
[TBL] [Abstract][Full Text] [Related]
13. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod as a dermatological therapy.
Tran H; Moreno G; Shumack S
Expert Opin Pharmacother; 2004 Feb; 5(2):427-38. PubMed ID: 14996638
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod applied topically: A novel immune response modifier.
Tyring S
Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
17. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
Schaen L; Mercurio MG
Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
[TBL] [Abstract][Full Text] [Related]
18. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
19. [Application of imiquimod and resiquimod in dermatology].
Xu KJ; Liu YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):445-7. PubMed ID: 16900654
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod (Aldara cream).
Buck HW
Infect Dis Obstet Gynecol; 1998; 6(2):49-51. PubMed ID: 9702584
[No Abstract] [Full Text] [Related]
[Next] [New Search]